MET and hepatocellular carcinoma: In light of mounting evidence demonstrating that overactive c-Met signaling is a main driver of HCC progression and metastasis, we next explored the effects of NCTD on the c-Met signaling pathway by examining the expression of c-Met and phosphorylated c-Met (p-Met) by western blotting.